Figure 3

The median length of hospital stay (Table 3) was not significantly higher (6 days) for both HCQ and Favipiravir groups, compared to patients on standard care (7 days).
The median length of hospital stay (Table 3) was not significantly higher (6 days) for both HCQ and Favipiravir groups, compared to patients on standard care (7 days).